Evidence map›Paper›PMID 32184237›Full record

ArticlemBio2020

Gamma Interferon Is Required for

Jennifer D Helble, Rodrigo J Gonzalez, Ulrich H von Andrian, Michael N Starnbach

Open access · goldAbstract read
In one paragraph

Article in mBio, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.0field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 25 citations in OpenAlex.

  1. AFrontiers in immunology · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Cytotoxic CD4+ T Cells Are Induced during Infection with Chlamydia trachomatis.Journal of immunology (Baltimore, Md. : 1950) · 2024
    Article
  7. A TriAdj-AdjuvantedVaccines · 2024
    Article
  8. Article
  9. Review
  10. Article
  11. Protective Immunity againstInternational journal of molecular sciences · 2023
    Article
  12. Multi-component prime-boostFrontiers in immunology · 2022
    Article
  13. Article
  14. Host-Pathogen Interactions ofPathogens (Basel, Switzerland) · 2021
    Article
  15. T cell responses to Chlamydia.Pathogens and disease · 2021
    Review
  16. Article
  17. Article
  18. Article
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Jennifer D HelbleDepartment of Microbiology, Harvard Medical School, Boston, Massachusetts, USA.
Rodrigo J GonzalezDepartment of Immunology, Harvard Medical School, Boston, Massachusetts, USA.
Ulrich H von AndrianDepartment of Immunology, Harvard Medical School, Boston, Massachusetts, USA.
Michael N StarnbachDepartment of Microbiology, Harvard Medical School, Boston, Massachusetts, USA starnbach@hms.harvard.edu.
Harvard University · US

Funding

Cytotoxic T Cell Mediated Immunity to ChlamydiaR01AI039558 · NIAID · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI STARNBACH, MICHAEL N · 2001 to 2025
$15.6M
The EPI-STI Biostatistics and Bioinformatics Core (Cuzick/Wheeler)U19AI113187 · NIAID · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI WHEELER, COSETTE MARIE · 2014 to 2018
$12.6M
CYTOTOXIC T CELL MEDIATED IMMUNITY TO CHLAMYDIAR29AI039558 · NIAID · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI STARNBACH, MICHAEL N · 1996 to 2000
$135k
NIAID NIH HHS R01 AI039558NIAID NIH HHS R29 AI039558NIAID NIH HHS U19 AI113187
6 · The paper itself

Abstract

While there is no effective vaccine against

Indexed as

AnimalsCD4-Positive T-LymphocytesChlamydia InfectionsChlamydia trachomatisFemaleGenitaliaInterferon-gammaMiceMice, Inbred C57BLMice, KnockoutTh1 CellsInterferon-gammaChlamydiagenital tract immunityIFN-γinterferonsmucosal immunitymucosal pathogensT cells

Identifiers

PMID32184237
PMCPMC7078466
OpenAlexW3011158198

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.